The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
112110536 11211053 6 F 20150407 20160816 20150623 20160824 EXP DE-AMGEN-DEUNI2015059919 AMGEN 83.00 YR E M Y 0.00000 20160824 MD DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
112110536 11211053 1 PS panitumumab PANITUMUMAB 1 Intravenous (not otherwise specified) 520 MG, UNK 125147 520 MG SOLUTION FOR INJECTION
112110536 11211053 2 C OXALIPLATIN. OXALIPLATIN 1 Intravenous (not otherwise specified) 200 MG, UNK 0 200 MG
112110536 11211053 3 C RIBOFOLIN 2 Intravenous (not otherwise specified) 800 MG, UNK 0 800 MG
112110536 11211053 4 C 5-FU FLUOROURACIL 1 Intravenous (not otherwise specified) 800 MG, UNK 0 800 MG
112110536 11211053 5 C 5-FU FLUOROURACIL 1 Intravenous (not otherwise specified) 4800 MG, UNK 0 4800 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
112110536 11211053 1 Colorectal cancer metastatic
112110536 11211053 2 Colorectal cancer metastatic
112110536 11211053 3 Colorectal cancer metastatic
112110536 11211053 4 Colorectal cancer metastatic

Outcome of event

Event ID CASEID OUTC COD
112110536 11211053 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
112110536 11211053 Angina pectoris
112110536 11211053 Chest pain
112110536 11211053 Dermatitis
112110536 11211053 Dry skin
112110536 11211053 Nausea
112110536 11211053 Paraesthesia
112110536 11211053 Pruritus
112110536 11211053 Xerosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
112110536 11211053 1 20150407 0
112110536 11211053 2 20150407 0
112110536 11211053 3 20150407 0
112110536 11211053 4 20150407 0
112110536 11211053 5 20150407 0